DuChemBIO Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Net Income	7,609	7,994	4,001
Depreciation & Amortization	5,610	5,565	5,760
Loss (Gain) From Sale of Assets	0.18	0.18	-16.28
Asset Writedown & Restructuring Costs	-	-	30.7
Loss (Gain) From Sale of Investments	-387.82	-387.82	-92.13
Loss (Gain) on Equity Investments	-755.64	-1,106	69.64
Stock-Based Compensation	11.7	31.97	236.54
Provision & Write-off of Bad Debts	99.98	156.15	-165.84
Other Operating Activities	-2,259	-2,039	929.66
Change in Accounts Receivable	-1,851	-1,834	-131.89
Change in Inventory	239.27	-74.64	-534.11
Change in Accounts Payable	-670.35	-597.38	411.37
Change in Other Net Operating Assets	-904.42	-679.24	-2,057
Operating Cash Flow	6,742	7,029	8,441
Operating Cash Flow Growth	-	-16.73%	-
Capital Expenditures	-1,569	-1,589	-1,147
Sale of Property, Plant & Equipment	-	-	31
Sale (Purchase) of Intangibles	-124.72	-283.1	-150
Investment in Securities	-	11.06	-
Other Investing Activities	-201.41	-204.41	-132.8
Investing Cash Flow	-1,745	-1,816	-1,299
Long-Term Debt Repaid	-	-7,925	-7,766
Net Debt Issued (Repaid)	-7,515	-7,925	-7,766
Issuance of Common Stock	11,440	11,440	-
Other Financing Activities	-7.75	-7.75	-
Financing Cash Flow	3,918	3,507	-7,766
Foreign Exchange Rate Adjustments	-0.23	-	-0.19
Net Cash Flow	8,915	8,720	-624.54
Free Cash Flow	5,174	5,440	7,293
Free Cash Flow Growth	-	-25.41%	-
Free Cash Flow Margin	14.51%	15.28%	21.02%
Free Cash Flow Per Share	189.76	202.48	272.63
Cash Interest Paid	1,138	1,087	919.41
Cash Income Tax Paid	209.54	144.92	90.38
Levered Free Cash Flow	-	4,629	-
Unlevered Free Cash Flow	-	5,311	-
Change in Net Working Capital	-	1,555	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.